JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling

Oncogene
J BaiG Li

Abstract

JWA, a newly identified novel microtubule-associated protein (MAP), was recently demonstrated to be indispensable for the rearrangement of actin cytoskeleton and activation of MAPK cascades induced by arsenic trioxide (As(2)O(3)) and phorbol ester (PMA). JWA depletion blocked the inhibitory effect of As(2)O(3) on HeLa cell migration, but enhanced cell migration after PMA treatment. As cancer cell migration is a hallmark of tumor metastasis and the functional role of JWA in cancer metastasis is not understood, here we show that JWA has an important role in melanoma metastasis. Our data demonstrated that JWA knockdown increased the adhesion and invasion abilities of melanoma cells. Furthermore, JWA knockdown in B16-F10 and A375 melanoma cells significantly promoted the formation and growth of metastatic colonies in vivo. Moreover, in the tumor biopsies from human melanoma patients, JWA expression was significantly decreased in malignant melanoma compared with normal nevi. In addition, we found that JWA knockdown could intensify tumor integrin alpha(V)beta(3) signaling by regulating nuclear factor Sp1. These findings suggest that JWA suppresses melanoma metastasis and may serve a potential therapeutic target for human melanoma.

References

Jun 1, 1992·The Journal of Clinical Investigation·B Felding-HabermannD A Cheresh
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·A M MontgomeryD A Cheresh
May 1, 1997·The International Journal of Biochemistry & Cell Biology·M A Horton
Mar 18, 2000·Cancer Metastasis Reviews·R E SeftorM J Hendrix
Oct 24, 2000·Clinical and Experimental Dermatology·J C BeckerE Bröcker
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Nov 1, 2001·Annual Review of Cell and Developmental Biology·M D Sternlicht, Z Werb
May 14, 2003·Clinical & Experimental Metastasis·Brunhilde Felding-Habermann
Jan 6, 2004·Cellular and Molecular Life Sciences : CMLS·T RothhammerA-K Bosserhoff
Dec 22, 2004·The Journal of Biological Chemistry·Hua Zhou, Randall H Kramer
Dec 24, 2004·The New England Journal of Medicine·Vincenzo de GiorgiBenvenuto Giannotti
Mar 11, 2005·FEBS Letters·Marc SchwenekerKarin Moelling
Jan 25, 2006·Biochemical and Biophysical Research Communications·Shu HuangJian-Wei Zhou
Aug 22, 2006·Current Opinion in Cell Biology·Satyajit K Mitra, David D Schlaepfer
Sep 26, 2006·Biochemical Pharmacology·Maroesja J van Nimwegen, Bob van de Water
Feb 20, 2008·Biology of the Cell·Andrea C M SinananMark P Lewis
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jan 13, 2009·The Journal of Biological Chemistry·Chunming ChengJianxin Gu

❮ Previous
Next ❯

Citations

May 4, 2013·Carcinogenesis·Jodi A McKenzieDouglas Grossman
Jan 15, 2011·Journal of Translational Medicine·Gaetano SantulliGuido Iaccarino
Sep 17, 2011·Journal of Cancer Research and Clinical Oncology·Peng-Jin MeiJun-Nian Zheng
Mar 1, 2012·Journal of Cancer Research and Clinical Oncology·Jin BaiJun-Nian Zheng
Sep 5, 2013·Journal of Cancer Research and Clinical Oncology·Jin BaiJun-Nian Zheng
Jan 15, 2015·Molecular Medicine Reports·Xiang ChenTieliang Ma
Jun 6, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sangbin LeeYu-Kyoung Oh
Mar 11, 2016·Journal of Cancer Research and Clinical Oncology·Yansu ChenJianwei Zhou
Jan 26, 2013·Cancer Science·Yang YeJianwei Zhou
Sep 15, 2015·Acta Pharmacologica Sinica·Nithya RaoRuowen Ge
Feb 24, 2015·Medical Oncology·Peng-Jin MeiJun-Nian Zheng
Feb 6, 2015·Journal of Cancer Research and Clinical Oncology·Weimin WangSujun Zhou
May 24, 2011·Biochemical and Biophysical Research Communications·Yu WuJianwei Zhou
Mar 11, 2015·Biochemistry. Biokhimii︠a︡·G E MorozevichA E Berman
Apr 29, 2018·Journal of Experimental & Clinical Cancer Research : CR·Ruixia Huang, Einar K Rofstad
Mar 17, 2018·Experimental and Therapeutic Medicine·Hong Qi, Aiping Li
Feb 27, 2013·International Journal of Oncology·Lisette P YcoAndré S Bachmann
Jun 25, 2020·Journal of Experimental & Clinical Cancer Research : CR·Jun-Jie ChenJian-Wei Zhou
Jan 21, 2017·Experimental and Therapeutic Medicine·Sifeng TangLeping Li
Mar 29, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shouyu WangJianwei Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.